© APMIS. Published by John Wiley & Sons Ltd
Edited By: E. Ralfkiær and B. Norrild
Impact Factor: 1.933
ISI Journal Citation Reports © Ranking: 2015: 37/79 (Pathology); 84/123 (Microbiology); 120/151 (Immunology)
Online ISSN: 1600-0463
2015: Breast Cancer Virtual Issue
Differential effect of the expression of TGF-β pathway inhibitors, Smad-7 and Ski, on invasive breast carcinomas: relation to biologic behavior
Theohari I, Giannopoulou I, Magkou C, Nomikos A, Melissaris S, Nakopoulou L.
Evaluating TIMP-1, Ki67, and HER2 as markers for non-sentinel node metastases in breast cancer patients with micrometastases to the sentinel node
Tvedskov TF, Bartels A, Jensen MB, Paaschburg B, Kroman N, Balslev E, Brünner N.
High expression of miR-21 in tumor stroma correlates with increased cancer cell proliferation in human breast cancer
Rask L, Balslev E, Jørgensen S, Eriksen J, Flyger H, Møller S, Høgdall E, Litman T, Nielsen BS.
Genetic polymorphisms of TP53-binding protein 1 (TP53BP1) gene and association with breast cancer risk
Naidu R, Har YC, Taib NA.
Mutational analysis of VACM-1/cul5 exons in cancer cell lines
Lewis SP, Willis AN, Johnson AE, Resau J, Burnatowska-Hledin MA.
Expression of midkine and endoglin in breast carcinomas with different immunohistochemical profiles
Qin Li L, Huang HL, Ping JL, Xu W, Li J, Dai LC.
Integrin β3 and its ligand regulate the expression of uPA through p38 MAPK in breast cancer
Wang R, Li ZQ, Han X, Li BL, Mi XY, Sun LM, Song M, Han YC, Zhao Y, Wang EH.
Pulmonary myoepithelial carcinoma resembling matrix-producing carcinoma of the breast: case report and review of the literature
Tanahashi J, Kashima K, Daa T, Yada N, Tanaka K, Kawano Y, Yokoyama S.
Secondary breast cancer: a 5-year population-based study with review of the literature
Klingen TA, Klaasen H, Aas H, Chen Y, Akslen LA.
Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
Maehle BO, Collett K, Tretli S, Akslen LA, Grotmol T.